Jermaine D Jones

Summary

Publications

  1. ncbi Strain-dependent sex differences in the effects of alcohol on cocaine-induced taste aversions
    Jermaine D Jones
    Psychopharmacology Laboratory, Department of Psychology, American University, 4400 Massachusetts Ave, NW, Washington, DC 20016, USA
    Pharmacol Biochem Behav 83:554-60. 2006
  2. doi The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users
    Jermaine D Jones
    Division of Substance Abuse, New York Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, Unit 120, New York, NY 10032, USA Electronic address
    Physiol Behav 159:33-9. 2016
  3. pmc The reinforcing and subjective effects of intravenous and intranasal buprenorphine in heroin users
    Jermaine D Jones
    Division on Substance Abuse, New York Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, Unit 120, New York, NY 10032, USA Electronic address
    Pharmacol Biochem Behav 122:299-306. 2014
  4. pmc Brief overdose education can significantly increase accurate recognition of opioid overdose among heroin users
    Jermaine D Jones
    Division on Substance Abuse, New York State Psychiatric Institute, Columbia University, College of Physicians and Surgeons, 1051 Riverside Drive, New York, NY 10032, United States Electronic address
    Int J Drug Policy 25:166-70. 2014
  5. pmc Opioid-like effects of the neurokinin 1 antagonist aprepitant in patients maintained on and briefly withdrawn from methadone
    Jermaine D Jones
    Division on Substance Abuse, New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Am J Drug Alcohol Abuse 39:86-91. 2013
  6. pmc Differential involvement of the norepinephrine, serotonin and dopamine reuptake transporter proteins in cocaine-induced taste aversion
    Jermaine D Jones
    Substance Use Research Center, New York State Psychiatric Institute Columbia University, 1051 Riverside Dr, New York, NY 10032, USA
    Pharmacol Biochem Behav 93:75-81. 2009
  7. pmc Dopamine, norepinephrine and serotonin transporter gene deletions differentially alter cocaine-induced taste aversion
    Jermaine D Jones
    Psychopharmacology Laboratory, Department of Psychology, American University, Washington, D C, USA
    Pharmacol Biochem Behav 94:580-7. 2010
  8. pmc Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone
    Perrine Roux
    Division on Substance Abuse, New York State Psychiatric Institute, Department of Psychiatry, and College of Physicians and Surgeons, Columbia University, 1051 Riverside Dr, Unit 120, New York, NY 10032, USA
    Pain 154:1442-8. 2013
  9. pmc Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addicts
    Sandra D Comer
    Department of Psychiatry, Division on Substance Abuse, New York State Psychiatric Institute, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, Unit 120, New York, NY 10032, USA
    Behav Pharmacol 24:504-16. 2013
  10. pmc Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers
    Sandra D Comer
    Department of Psychiatry, Division on Substance Abuse, New York State Psychiatric Institute, and College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Neuropsychopharmacology 38:2427-38. 2013

Collaborators

Detail Information

Publications26

  1. ncbi Strain-dependent sex differences in the effects of alcohol on cocaine-induced taste aversions
    Jermaine D Jones
    Psychopharmacology Laboratory, Department of Psychology, American University, 4400 Massachusetts Ave, NW, Washington, DC 20016, USA
    Pharmacol Biochem Behav 83:554-60. 2006
    ..That such an interaction is evident suggests that attention to such factors in assessing the effects of drug combinations is important to understanding the likelihood of the use and abuse of such drugs...
  2. doi The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users
    Jermaine D Jones
    Division of Substance Abuse, New York Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, Unit 120, New York, NY 10032, USA Electronic address
    Physiol Behav 159:33-9. 2016
    ..The proposed investigation sought to examine the effects of PIO on the subjective, analgesic, physiological and cognitive effects of oxycodone (OXY)...
  3. pmc The reinforcing and subjective effects of intravenous and intranasal buprenorphine in heroin users
    Jermaine D Jones
    Division on Substance Abuse, New York Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, Unit 120, New York, NY 10032, USA Electronic address
    Pharmacol Biochem Behav 122:299-306. 2014
    ..Nevertheless, the present data demonstrate that in participants maintained on a low dose of SL BUP, the medication itself has abuse liability when used intravenously or intranasally...
  4. pmc Brief overdose education can significantly increase accurate recognition of opioid overdose among heroin users
    Jermaine D Jones
    Division on Substance Abuse, New York State Psychiatric Institute, Columbia University, College of Physicians and Surgeons, 1051 Riverside Drive, New York, NY 10032, United States Electronic address
    Int J Drug Policy 25:166-70. 2014
    ..The current study sought to assess the ability of NYSDOH training to increase accurate identification of opioid and non-opioid overdose, and naloxone use among heroin users...
  5. pmc Opioid-like effects of the neurokinin 1 antagonist aprepitant in patients maintained on and briefly withdrawn from methadone
    Jermaine D Jones
    Division on Substance Abuse, New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Am J Drug Alcohol Abuse 39:86-91. 2013
    ..This investigation sought to examine the ability of the NK1 antagonist aprepitant to alter the effects of methadone as well as withdrawal symptoms induced by brief methadone discontinuation...
  6. pmc Differential involvement of the norepinephrine, serotonin and dopamine reuptake transporter proteins in cocaine-induced taste aversion
    Jermaine D Jones
    Substance Use Research Center, New York State Psychiatric Institute Columbia University, 1051 Riverside Dr, New York, NY 10032, USA
    Pharmacol Biochem Behav 93:75-81. 2009
    ..Combined, the results of these investigations indicate little or no involvement of dopaminergic systems in cocaine's aversive effects while NE appears to contribute most substantially, with a possible modulatory involvement by serotonin...
  7. pmc Dopamine, norepinephrine and serotonin transporter gene deletions differentially alter cocaine-induced taste aversion
    Jermaine D Jones
    Psychopharmacology Laboratory, Department of Psychology, American University, Washington, D C, USA
    Pharmacol Biochem Behav 94:580-7. 2010
    ..The data lead us to conclude that the action of cocaine to inhibit NET contributes most substantially to its aversive effects, with some involvement of SERT and minimal contribution of DAT...
  8. pmc Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone
    Perrine Roux
    Division on Substance Abuse, New York State Psychiatric Institute, Department of Psychiatry, and College of Physicians and Surgeons, Columbia University, 1051 Riverside Dr, Unit 120, New York, NY 10032, USA
    Pain 154:1442-8. 2013
    ..These data suggest that Bup/Nx was effective in reducing pain and supplemental oxycodone use. Importantly, adequate management of pain and withdrawal symptoms by Bup/Nx may reduce oxycodone preference in this population...
  9. pmc Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addicts
    Sandra D Comer
    Department of Psychiatry, Division on Substance Abuse, New York State Psychiatric Institute, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, Unit 120, New York, NY 10032, USA
    Behav Pharmacol 24:504-16. 2013
    ..Both self-administration procedures were effective for assessing the relative reinforcing effects of drugs; preference for one procedure should be driven by the specific research question of interest. ..
  10. pmc Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers
    Sandra D Comer
    Department of Psychiatry, Division on Substance Abuse, New York State Psychiatric Institute, and College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Neuropsychopharmacology 38:2427-38. 2013
    ..Future studies should continue to evaluate NTX as a potential anti-craving medication for COC dependence. ..
  11. pmc A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin® (non-TRF) in prescription opioid abusers
    Suzanne K Vosburg
    Division on Substance Abuse, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA
    Addiction 108:1095-106. 2013
    ....
  12. pmc Impact of in-patient research participation on subsequent heroin use patterns: implications for ethics and public health
    Perrine Roux
    Substance Use Research Center, NYSPI, Columbia University, New York, NY 10032, USA
    Addiction 107:642-9. 2012
    ..The primary objective of this study was to assess whether participation in such research alters the frequency of heroin use by non-treatment-seeking opioid-dependent volunteers after study completion...
  13. pmc Oxycodone abuse in New York City: characteristics of intravenous and intranasal users
    Jermaine D Jones
    Division on Substance Abuse, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA
    Am J Addict 20:190-5. 2011
    ..Additional research is needed to confirm these observed differences, yet these data may assist treatment efforts by providing information to guide targeted treatment and population-specific interventions. ..
  14. pmc The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers
    Ziva D Cooper
    Division on Substance Abuse, New York Psychiatric Institute, Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Addict Biol 21:895-903. 2016
    ..These exploratory findings are the first to demonstrate the potential clinical utility of glial modulators for treating opioid withdrawal in humans. ..
  15. pmc Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users
    Jermaine D Jones
    Division of Substance Abuse, New York Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY, USA
    Addict Biol 20:784-98. 2015
    ..These data strongly argue in favor of buprenorphine/naloxone rather than buprenorphine alone as the more reasonable option for managing the risk of buprenorphine misuse...
  16. pmc Assessment of a formulation designed to be crush-resistant in prescription opioid abusers
    Suzanne K Vosburg
    Division on Substance Abuse, New York State Psychiatric Institute, Columbia University College of Physicians and Surgeons, Department of Psychiatry, 1051 Riverside Drive, Unit 120, New York, NY 10032, USA
    Drug Alcohol Depend 126:206-15. 2012
    ....
  17. ncbi Racial Differences in HIV and HCV Risk Behaviors, Transmission, and Prevention Knowledge among Non-Treatment-Seeking Individuals with Opioid Use Disorder
    Verena E Metz
    a Postdoctoral Research Scientist, Department of Psychiatry, Division on Substance Abuse, New York State Psychiatric Institute and Columbia University Medical Center, New York, NY, USA
    J Psychoactive Drugs . 2016
    ..Better HIV/HCV prevention interventions targeting individuals with opioid use disorders who are not currently in treatment would be desirable, given their large health burden...
  18. pmc Polydrug abuse: a review of opioid and benzodiazepine combination use
    Jermaine D Jones
    Division on Substance Abuse, New York Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, Unit 120, New York, NY 10032, USA
    Drug Alcohol Depend 125:8-18. 2012
    ..Physicians should address this important and underappreciated problem with more cautious prescribing practices, and increased vigilance for abusive patterns of use...
  19. pmc Need and utility of a polyethylene glycol marker to ensure against urine falsification among heroin users
    Jermaine D Jones
    Division of Substance Abuse, New York State Psychiatric Institute College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, New York, NY 10032, USA Electronic address
    Drug Alcohol Depend 153:201-6. 2015
    ..The goal of this study was to determine the effectiveness of using the PEG marker system among active heroin users screening for research studies...
  20. pmc The subjective, reinforcing, and analgesic effects of oxycodone in patients with chronic, non-malignant pain who are maintained on sublingual buprenorphine/naloxone
    Jermaine D Jones
    Division on Substance Abuse, New York State Psychiatric Institute College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Neuropsychopharmacology 36:411-22. 2011
    ..These data suggest that sublingual Bup/Nx has the potential as an analgesic medication and further research should investigate its use in treating patients with chronic pain who abuse opioids...
  21. pmc The effects of heroin administration and drug cues on impulsivity
    Jermaine D Jones
    a Division on Substance Abuse, New York State Psychiatric Institute, Columbia University Medical Center, New York, NY, USA
    J Clin Exp Neuropsychol 38:709-20. 2016
    ..A better understanding of these factors could provide critical insight into the maintenance of heroin use and relapse. ..
  22. pmc Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances
    Ziva D Cooper
    College of Physicians and Surgeons of Columbia University, New York State Psychiatric Institute and Department of Psychiatry, Division on Substance Abuse, 1051 Riverside Drive, New York, NY 10032, USA
    Expert Opin Investig Drugs 21:169-78. 2012
    ....
  23. pmc A review of pharmacogenetic studies of substance-related disorders
    Jermaine D Jones
    Division on Substance Abuse, New York State Psychiatric Institute and Columbia University College of Physicians and Surgeons, 1051 Riverside Dr, New York, NY 10032, United States Electronic address
    Drug Alcohol Depend 152:1-14. 2015
    ..To determine the impact of genetic variation on risk for SRD and the response to treatment, researchers have conducted a number of secondary data analyses and quasi-experimental studies that target one or more candidate gene variants...
  24. doi Searching for evidence of genetic mediation of opioid withdrawal by opioid receptor gene polymorphisms
    Jermaine D Jones
    Division of Substance Abuse, New York Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, Unit 120, 10032, New York, New York
    Am J Addict 25:41-8. 2016
    ..Previous research has identified many genetic polymorphisms that appear to mediate the effects of opioid drugs. However, the relationship between genetic polymorphisms and the severity of opioid withdrawal has not yet been characterized...
  25. pmc The pharmacogenetics of alcohol use disorder
    Jermaine D Jones
    Division on Substance Abuse, New York State Psychiatric Institute and Columbia University College of Physicians and Surgeons, New York, New York
    Alcohol Clin Exp Res 39:391-402. 2015
    ..These variants, which we review here, were chosen based upon their observed or hypothesized functional relevance to alcohol use disorder (AUD) risk or to the mechanism by which medications used to treat the disorder exert their effects...
  26. pmc A review of human drug self-administration procedures
    Jermaine D Jones
    Department of Psychiatry, Division on Substance Abuse, New York Psychiatric Institute, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA
    Behav Pharmacol 24:384-95. 2013
    ..The present paper summarizes the different self-administration techniques that are commonly used today and the application of other procedures that may complement interpretation of the drug self-administration findings. ..